Philamer Calses

965 total citations · 1 hit paper
6 papers, 648 citations indexed

About

Philamer Calses is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Philamer Calses has authored 6 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Philamer Calses's work include DNA Repair Mechanisms (2 papers), MicroRNA in disease regulation (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Philamer Calses is often cited by papers focused on DNA Repair Mechanisms (2 papers), MicroRNA in disease regulation (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Philamer Calses collaborates with scholars based in United States, France and Japan. Philamer Calses's co-authors include James J. Crawford, Jennie R. Lill, Anwesha Dey, Yemin Wang, Toshiyasu Taniguchi, Jen‐Wei Huang, Christopher J. Kemp, Kamel Izeradjene, Amy Chang and Martin C. Whittle and has published in prestigious journals such as Cell, Cancer Research and Cell Reports.

In The Last Decade

Philamer Calses

6 papers receiving 644 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities

2019 279 citations Philamer Calses, James J. Crawford et al. Trends in cancer profile →

Peers

Philamer Calses

MB

CR

CB

ONCOL

PRM

Jing Pei China

Matteo Toller Italy

Dejan Maglic United States

Tse-Ming Hong Taiwan

Andrea Bisso Italy

Juan M. Schvartzman United States

Shahryar E. Mir Netherlands

Elsa Krall United States

Melissa Hector-Greene United States

Jing Pei China

Philamer Calses

374 ×0.8

MB

168 ×0.8

CR

249 ×1.2

CB

123 ×0.6

ONCOL

33 ×0.8

PRM

Citations per year, relative to Philamer Calses Philamer Calses (= 1×) peers Jing Pei

Countries citing papers authored by Philamer Calses

Since Specialization

Citations

This map shows the geographic impact of Philamer Calses's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philamer Calses with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philamer Calses more than expected).

Fields of papers citing papers by Philamer Calses

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philamer Calses. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philamer Calses. The network helps show where Philamer Calses may publish in the future.

Co-authorship network of co-authors of Philamer Calses

This figure shows the co-authorship network connecting the top 25 collaborators of Philamer Calses. A scholar is included among the top collaborators of Philamer Calses based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philamer Calses. Philamer Calses is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Wang, Yan, Allison W. Roberts, Philamer Calses, et al.. (2024). Abstract 5949: The clinical dual KRASG12C inhibitor FMC-376 has demonstrated potential as both a monotherapy and in combination for the treatment of patients with KRASG12C mutation positive NSCLC. Cancer Research. 84(6_Supplement). 5949–5949. 1 indexed citations

2.

Calses, Philamer, James J. Crawford, Jennie R. Lill, & Anwesha Dey. (2019). Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities. Trends in cancer. 5(5). 297–307. 279 indexed citations breakdown →

3.

Calses, Philamer, Kiranjit K. Dhillon, Yong Chi, et al.. (2017). DGCR8 Mediates Repair of UV-Induced DNA Damage Independently of RNA Processing. Cell Reports. 19(1). 162–174. 28 indexed citations

4.

Whittle, Martin C., Kamel Izeradjene, Priya Rani, et al.. (2015). RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma. Cell. 161(6). 1345–1360. 156 indexed citations

5.

Huang, Jen‐Wei, Yemin Wang, Kiranjit K. Dhillon, et al.. (2013). Systematic Screen Identifies miRNAs That Target RAD51 and RAD51D to Enhance Chemosensitivity. Molecular Cancer Research. 11(12). 1564–1573. 81 indexed citations

6.

Wang, Yemin, Jen‐Wei Huang, Philamer Calses, Christopher J. Kemp, & Toshiyasu Taniguchi. (2012). MiR-96 Downregulates REV1 and RAD51 to Promote Cellular Sensitivity to Cisplatin and PARP Inhibition. Cancer Research. 72(16). 4037–4046. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact